CBS 2019
CBSMD教育中心
中 文

Percutaneous LAA Occlusion

Abstract

Recommended Article

Comparison of the Efficacy and Safety Outcomes of Edoxaban in 8040 Women Versus 13 065 Men With Atrial Fibrillation in the ENGAGE AF-TIMI 48 Trial Gut microbiota dysbiosis promotes age-related atrial fibrillation by lipopolysaccharide and glucose-induced activation of NLRP3-inflammasome Short-Term Oral Anticoagulation Versus Antiplatelet Therapy Following Transcatheter Left Atrial Appendage Closure Anticoagulation in Concomitant Chronic Kidney Disease and Atrial Fibrillation: JACC Review Topic of the Week Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial Alcohol consumption, cardiac biomarkers, and risk of atrial fibrillation and adverse outcomes Early Rhythm-Control Therapy in Patients with Atrial Fibrillation

Original ResearchVolume 15, Issue 7, 11 April 2022, Pages 685-697

JOURNAL:J Am Coll Cardiol Intv. Article Link

Minimum Core Data Elements for Evaluation of TAVR: A Scientific Statement by PASSION CV, HVC, and TVT Registry

M Simonato, S Vemulapalli, OB-Yehuda et al. Keywords: TAVR; clinical trail design; variable

Full Text PDF